Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2024-01-12 00:00:00 ET · period of report 2024-01-10 · accession 0001209191-24-001593 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-12 | 2024-01-10 | TMCI | Berutti Aaron | SVP, Sales | A - Grant | $0.00 | +65.0K | 107.9K | +152% | $0 |
| D | 2024-01-12 | 2024-01-10 | TMCI | Berutti Aaron | SVP, Sales | A - Grant | $0.00 | +73.2K | 73.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-10 | A | A | 65,025 | $0.00 | 107,867 | D | — | — | (F1) Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and with the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date. (F2) Includes 103,787 RSUs. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-01-10 | A | A | 73,200 | $0.00 | 73,200 | D | $13.46 · — to 2034-01-10 | 73,200 Stock Option (Right to Buy) | (F3) The stock option vests in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028, subject to Reporting Person's providing continued service to Issuer through each vesting date. |